Showing results (1071-1080 of 1,911) with videos related to
Sort By:
Pageof 192
Current Neuropharmacology|December 29, 2018
Why Should Psychiatrists and Neuroscientists Worry about Paraoxonase 1?Estefania Gastaldello Moreira, Karine Maria Boll, Dalmo Guilherme Correia, et al.Current Neuropharmacology|February 24, 2018
The Role of LRRK2 in Neurodegeneration of Parkinson DiseaseQin Rui, Haibo Ni, Di Li, et al.Current Neuropharmacology|February 24, 2018
The Role of VE-cadherin in Blood-brain Barrier Integrity Under Central Nervous System Pathological ConditionsWenlu Li, Zhigang Chen, Ian Chin, et al.Current Neuropharmacology|May 25, 2022
Pharmacokinetic Interactions Between Antiseizure and Psychiatric MedicationsGaetano Zaccara, Valentina FrancoCurrent Neuropharmacology|July 7, 2022
Bipolar Disorder and Manic-Like Symptoms in Alzheimer's, Vascular and Frontotemporal Dementia: A Systematic ReviewCamilla Elefante, Giulio Emilio Brancati, Samuele Torrigiani, et al.Current Neuropharmacology|July 7, 2022
Nanocarrier-Based Drug Delivery to Brain: Interventions of Surface ModificationSurbhi Sharma, Shweta DangCurrent Neuropharmacology|July 7, 2022
Epilepsy and Autism Spectrum Disorder (ASD): The Underlying Mechanisms and Therapy Targets Related to AdenosineMengyi Guo, Pandeng Xie, Siqi Liu, et al.Current Neuropharmacology|July 7, 2022
Comparative Analysis of the Pre- and Post-Medication Effects of Antipsychotic Agents on the Blood-Based Oxidative Stress Biomarkers in Patients with Schizophrenia: A Meta-AnalysisMi Yang, Chunzhi Wang, Guocheng Zhao, et al.Current Neuropharmacology|January 12, 2021
Chlorogenic Acid Improves PTSD-like Symptoms and Associated MechanismsXing-Dong Chen, Jun-Jie Tang, Shuang Feng, et al.Current Neuropharmacology|June 2, 2021
Poloxamer 188 (P188), A Potential Polymeric Protective Agent for Central Nervous System Disorders: A Systematic ReviewWin Ning Chen, Mohd Farooq Shaikh, Saatheeyavaane Bhuvanendran, et al.Pageof 192